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Background: High-ﬁeld 3.0 T MR scanners provide an improved signal-to-noise ratio which can be
translated in higher image resolution, possibly allowing critical detection of subtle epileptogenic lesions
missed on standard-ﬁeld 1.0–1.5 T MRIs. In this study, the authors explore the potential value of re-
imaging at 3.0 T patients with refractory partial epilepsy and negative 1.5 T MRI.
Methods: We retrospectively identiﬁed all patients with refractory partial epilepsy candidate for surgery
who had undergone a 3.0 T MR study after a negative 1.5 T MR study. High-ﬁeld 3.0 T MRIs were
reviewed qualitatively by neuroradiologists experienced in interpreting epilepsy studies with access to
clinical information. Relevance and impact on clinical management were assessed by an epileptologist.
Results: Between November 2006 and August 2009, 36 patients with refractory partial epilepsy
candidate for surgery underwent 3.0 T MR study after a 1.5 T MR study failed to disclose a relevant
epileptogenic lesion. A potential lesion was found only in two patients (5.6%, 95% CI: 1.5–18.1%). Both
were found to have hippocampal atrophy congruent with other presurgical localization techniques
which resulted in omission of an invasive EEG study and direct passage to surgery.
Conclusions: The frequency of detection of a new lesion by re-imaging at 3.0 T patients with refractory
partial epilepsy candidate for surgery was found to be low, but seems to offer the potential of a
signiﬁcant clinical impact for selected patients. This ﬁnding needs to be validated in a prospective
controlled study.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Despite the regular introduction of new anticonvulsants on the
market, many epileptic patients continue to have drug-resistant
seizures. Their best option is often to consider surgery. In the
context of epilepsy surgery, the main challenge is ﬁnding the
precise location of the epileptogenic zone in the brain, in order to
remove it and end the seizures. In the presurgical evaluation, MRI
(Magnetic resonance imaging) is particularly useful in that aspect
as the location of a structural lesion is usually congruent with the
epileptogenic zone. Several studies conﬁrm that detection of an
epileptogenic lesion onMRI substantially improves the outcome of
an epilepsy surgery.1,2
The strength of the magnetic ﬁeld of an MRI scanner is
measured in Tesla (T). Many refer to ﬁeld strengths3.0 T as ‘high-* Corresponding author at: Service de Neurologie, Hoˆpital Notre-Dame du CHUM,
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doi:10.1016/j.seizure.2010.07.002ﬁeld’, 1.0–2.0 T as ‘standard’, and <0.5 T as ‘low ﬁeld’. The vast
majority of epilepsy protocol MRI studies are currently performed
on a 1.0–1.5 T scanner and include (a) a volume acquisition T1-
weighted data set acquired in an oblique coronal orientation and
covering the whole brain in 0.9 mm partitions; (b) an oblique
coronal spin-echo sequence, with proton density, heavily T2-
weighted and FLAIR acquisitions that are orientated perpendicular
to the long axis of the hippocampus.3 Using these conventional
acquisitions, abnormalities are detected in 80% of patients with
refractory temporal lobe epilepsy but in only 50–60% of patients
with refractory neocortical epilepsy.4 High-ﬁeld 3 T MRIs were
approved recently by the American Food and Drug Administration
(FDA) for clinical use and have been introduced progressively in
academic centers over the last few years. High-ﬁeld MRIs provide
an improved signal-to-noise ratio which could theoretically result
in higher image resolution, possibly allowing critical detection of
subtle epileptogenic lesions missed on standard ﬁeld MRIs.5 The
question arises whether patients with refractory partial epilepsy
and a previously negative 1.5 TMRI should be re-imagedwith a 3 T
MRI now that these are more popular. We address this issue in this
retrospective study.vier Ltd. All rights reserved.
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We retrospectively identiﬁed all refractory partial epilepsy
patients candidate for epilepsy surgery in whom a 3.0 T epilepsy
protocol MRI was performed between November 2006 and August
2009 because a previous standard ﬁeld MRI (1.0–1.5 T) had failed
to identify a relevant epileptogenic lesion. Patients were eligible if
they had undergone a comprehensive presurgical evaluation
including a clinical history and examination, long-term video-
EEG monitoring for recording of seizures, and at least one epilepsy
protocol head-coil standard ﬁeld (1.0–1.5 T) MRI scan at our center
or an afﬁliated academic center. All standard-ﬁeld MRIs had been
read previously by an unblinded experienced neuroradiologist. The
study was approved by our institutional ethics committee with
waiver of informed consent.
2.1. MRI
The initial 3.0 T scans were performed at the CRIUGM, a
research center afﬁliated with the University of Montreal on a
Siemens Tim TRIO (Siemens AG, Berlin, Germany). The remaining
3.0 T scans were performed at Notre-Dame Hospital when the
Achieva Dual 3.0 T system was installed in January 2008 (Philips
Medical Systems, Best, Netherlands). All 3.0 T studies included (a) a
3D T1-weighted gradient-echo acquisition of the whole brain (TR/
TE, 24/6; ﬂip angle, 258; ﬁeld of view, 256 mm  256 mm; matrix,
256  192); (b) axial T2-weighted (TR/TE, 24/6; ﬂip angle, 258;
ﬁeld of view, 256 mm  256 mm; matrix, 256  192) and FLAIR
(TR/TE, 24/6; ﬂip angle, 258; ﬁeld of view, 256 mm  256 mm;
matrix, 256  192) acquisitions of the whole brain; (c) coronal T2-
weighted and FLAIR acquisitions perpendicular to the longitudinal
axis of the hippocampus. Intravenous contrast agents were given
only if a mass lesion was demonstrated.
2.2. Image review
High-ﬁeld MRIs were reviewed qualitatively by neuroradiolo-
gists experienced in interpreting epilepsy studies and with access
to clinical information. If an abnormality was identiﬁed on the
high-ﬁeld MRI study, the ﬁnding was interpreted by an epileptol-
ogist to determine whether the abnormality was relevant to the
patient’s epileptic condition and if it resulted in a change in clinical
management. The localization of each patient’s epileptogenic zone
was determined based on multimodal analysis of clinical,
electrophysiological (scalp EEG, MEG) and functional (PET, SPECT,
EEG-fMRI) data. Findings from intracerebral ﬁndings, pathological
examination of the tissue resected and surgical outcome were also
used when available.
3. Results
3.1. Patients
We identiﬁed 36 (20 M/16 F; age 13–56 yo/median 31 yo)
patients with refractory partial epilepsy candidate for epilepsy
surgery whose 1.5 T MRI failed to detect a relevant epileptogenic
lesion and who underwent re-imaging at 3.0 T between November
2006 and August 2009.Median interval between the twoMRIs was
22.5 months (range 0 day–13 years). Localization of the epilepto-
genic zonewas based onmultimodal analysis of clinical, scalp EEG,
functional (SPECT and PET) data for all patients. Magnetoencepha-
lography was obtained in 26 subjects and EEG-fMRI in 24 subjects.
Additional invasive EEG ﬁndings were available for 10 patients.
Sixteen had frontal lobe epilepsy, 15 had temporal lobe epilepsy,
three had parietal lobe epilepsy and two had occipital lobe
epilepsy.3.2. Standard-ﬁeld MRI
As determined by our inclusion criteria, standard-ﬁeld MRI
failed to reveal a congruent epileptogenic lesion in all patients.
Twenty-ﬁve were performed at our institution using our epilepsy
protocol. The remaining cases were scanned in other afﬁliated
academic hospitals also beneﬁting from an epilepsy protocol. Ten
patients had unspeciﬁc or unrelated brain abnormalities on their
1.5 T MRI: Chiari type I malformation (1), arachnoid cyst (1), small
white matter signal abnormalities (4), quadrigeminal plate lipoma
(1), mild atrophy (2), or slight malrotation of hippocampus (1) but
contralateral to the suspected epileptogenic zone.
3.3. High-ﬁeld MRI
High-ﬁeld MRIs were obtained using a 3.0 T Siemens Tim TRIO
(Siemens AG, Berlin, Germany) in 11 cases and a Philips Achieva
Dual 3T (Philips Medical Systems, Best, Netherlands) in the other
25. High-ﬁeld imaging identiﬁed an abnormality in two out of 36
patients (5.6%) (see Table 1). A mild left hippocampal atrophy was
discovered for case 6 whose electroclinical data suggested left
mesial temporal lobe epilepsy. A mild right hippocampal atrophy
was found for case 13 whose presurgical evaluation suggested
right mesial temporal lobe epilepsy. Intervals between standard
and high-ﬁeld MRI studies for both patients were 32 and 10
months, respectively. In light of these ﬁndings, it was decided to
omit the invasive EEG study in both cases. Patient 13 underwent a
right anterior temporal lobectomy with Engel 1 outcome (31
months follow-up) while Patient 6 is waiting to be operated. Of the
10 patients with unspeciﬁc or incongruent ﬁndings on their 1.5 T
MRI, 3.0 T imaging provided no further information. One patient
with negative 1.5 T MRI was found to have a small white matter
signal abnormality far from and contralateral to the suspected
epileptogenic zone.
4. Discussion
Outcome of epilepsy surgery is intimately linked to accurate
localization of the epileptogenic zone.6 Any technique enabling our
capacity to detect an underlying pathological substrate is bound to
increase our chance to delimit this epileptogenic zone. Introduc-
tion in the 1980s of MRI for clinical use has revolutionized the
evaluation of partial epilepsy, unveiling previously undetected
lesions such as cortical developmental malformations and
hippocampal atrophy. This in turn has led to better surgical
outcome, reduced need for intracranial EEG studies as well as
disclosing a new population of potential candidates for epilepsy
surgery. Because numerous studies have shown such a strong
correlation between seizure relief and resection of a visible
structural lesion, ﬁnding evidence for such an epileptogenic lesion
has assumed an important role in the presurgical work-up of
patients with intractable partial epilepsy.7
Most hospitals are equipped with a commercial whole-body
magnet operating at 1.0–1.5 T. Several studies have already shown
the beneﬁt of dedicated MRI protocols interpreted by experienced
neuroradiologists.8,9 Technological advances have allowed the
development of more powerful magnets and 3.0 T MR scanners
have been progressively installed worldwide for clinical use over
the last few years. A greater magnetic ﬁeld strength provides a
higher signal-to-noise ratio which in turn allows faster imaging for
a given resolution or higher resolution for a given imaging time.
The obvious implication for epilepsy patients is that higher ﬁeld
MRI has the potential to detect subtle epileptogenic lesions that
might have beenmissed by low-ﬁeld or standard-ﬁeldMRI. Formal
comparison is however required to conﬁrm improvements in the
detection of epileptogenic lesions by 3.0 T scanners over current
Table 1
Summary of clinical and presurgical ﬁndings, intracranial EEG results, and surgical outcome.
Patient Epilepsy MRI 1.5T; detected
epileptogenic lesion
MRI 1.5 T;
non-speciﬁc
abnormality
MRI 3T
added ﬁndings
ICE Surgery Outcome
(Engel)
F-U
(mo)
Pathology
1 R FLE No No No No
2 R FLE No Small WMSA No No No
3 Bi-MTLE No No No No
4 R FLE No No No No
5 R NTLE Slight malrotation of
contra-lateral L hippocampus
vs variant
No No No
6 L MTLE No Yes (mild L HA) No No
7 Bi-MTLE (L:R) Contralateral mild R HA No Yes L ATL I 3 CA1,3,4 cell loss,
gliosis
8 R NTLE No Chiari type I No No No
9 R FLE No No Yes R F corticectomy I 2 Pending
10 L NTLE No No No No
11 L FLE No Small lipoma,
small WMSA
No No No
12 L NTLE No No No No
13 R MTLE No Yes (mild R HA) No R ATL I 22 CA1 cell loss, gliosis
14 R FLE No Small WMSA No Yes R F corticectomy I 23 normal
15 R PLE No No Yes R P corticectomy I 22 Cortical dysplasia
16 R FLE No No Yes R F corticectomy I 23 Cortical dysplasia
17 L FLE No No No No
18 L NTLE No No No No
19 R MTLE Contralateral mild L HA No Yes R SAH I 24 Not available
20 L NTLE No No No No
21 R FLE No No No No
22 L FLE No No Yes L F corticectomy IV 24 Microdysgenesis
23 R OLE No No Yes R O corticectomy I 12 Normal
24 R MTLE No No Yes R ATL I 4 CA1, 3,
4 cell loss, gliosis
25 L NTLE No No No No
26 L PLE No No No No
27 bi-MTLE No Small WMSA No No No
28 L NTLE No No No No
29 L FLE No No No No
30 R PLE No No No No
31 L FLE No No (small WMSA) No No
32 R FLE No Discrete vermal
atrophy
No No No
33 R FLE No No No No
34 OLE No No No No
35 L FLE No No No No
36 R FLE R HA but suspected EZ is R frontal No Yes No
Abbreviations: R, right; L, left; NTLE, neocortical temporal lobe epilepsy; MTLE, mesial temporal lobe epilepsy; FLE, frontal lobe epilepsy; PLE, parietal lobe epilepsy; OLE,
occipital lobe epilepsy; ICE, intracranial electroencephalogram; HA, hippocampal atrophy;WMSA, white matter signal abnormality; ATL, anterior temporal lobectomy; SAH,
selective amygdalo-hippocampectomy; EZ, epileptogenic zone; Engel classiﬁcation: I, free of impairing seizures; II, rare disabling seizures; III, worthwhile improvement; IV,
no worthwhile improvement.
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at higher ﬁeld. These include increased susceptibility artefact from
magnetic ﬁeld inhomogeneity in orbitofrontal and temporal brain
regionsnearingair-ﬁllednasal cavitiesaswell aspoorerT1-weighted
contrast by convergence of tissue T1 values which may negate the
theoretical increase in signal to noise ratio over 1.5 T images.10,11
Our study shows that re-imaging non-lesional focal epilepsy
patients at 3.0 T provided clinical relevant ﬁndings in only two out
of 36 patients (5.6%). This estimation is also associated with a
substantial uncertainty (95% CI: 1.5–18.1%) related to this small
population. Despite this low detection rate, the abnormalities that
were found did have an impact on clinical management. Both were
found to have mild hippocampal atrophy congruent with other
presurgical ﬁndings, obviating the need for invasive EEG monitor-
ing. Higher-ﬁeld imaging also disclosed an unrelated lesion (small
white matter signal abnormality) in one case (false positive).
Limited studies have looked at the value of structural imaging at
higher ﬁeld for epilepsy. Volumetrically derived volumes of
amygdala and hippocampus from 1.5 and 3.0 T images did not
differ in eight healthy subjects12 and 10 temporal lobe epilepsy
patients.13 Grifﬁths et al.5 reported their initial experience ofimaging 120 adults with localisation-related epilepsy using MR
imaging at 3.0 T (SENSE head coil) but provided no comparison
with 1.5 T imaging data. In the only prospective study available,
Knake et al.11 reported that 3.0 T MRI with a custom-made eight-
channel ﬂexible receive-only phased array coil resulted in the
detection of a new lesion in 15 of 23 (65%) patients with medically
intractable focal epilepsy and normal 1.5 TMRI. Unfortunately, the
authors were unable to separate the beneﬁts of differences in
expertise between radiologists, use of higher ﬁeld strength, or use
of the phased array head coil. Similar dramatic detection rates of
new lesions have not been reported since. Phal et al.14 attempted a
formal comparison of standard and high-ﬁeld structural MRIs for
epilepsy by retrospectively reviewing images from 25 patients
who underwent both 1.5 T (with transmit-receive single-channel
head coil) and 3.0 T (with six-channel SENSE head coil) scanning.
MRI at 3.0 T outperformed MRI at 1.5 T for image quality
parameters (distortion and artefact, lesion conspicuity, gray–
white matter differentiation, and motion). Sub-analyses on the 19
patients with partial epilepsy revealed that lesions were detected
in 74% of cases done on 1.5 T MRI compared to 88% at 3.0 T. These
ﬁndings are however not directly comparable to our series as the
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imaging (such as previously normal or equivocal results at 1.5 T
but also lesional follow-up and surgical planning). In fact, only 5
cases out of 19 partial epilepsy patients had a negative 1.5 T MRI.
Strandberg et al.15 reported that 3.0 T (4 channel head coil and
parallel imaging) MRI provided new or additional information
about structural grey matter abnormalities, compared to reports
from 1.0 to 1.5 T MRI, in ﬁve (out of 25) patients (20%). In one 1.5 T
MRI-negative patient, a malformation of cortical development was
identiﬁed. In four other patients with unspeciﬁc ﬁndings (cortical
atrophy, heterotopia, increased signal changes after subpial
transection) on 1.0 or 1.5 T MRI, malformations of cortical
development were identiﬁed on 3.0 T MRI. The higher detection
rate compared to our ﬁndings could possibly be explained by the
fact that two of their patients would have been excluded in our
study. After removing the patient with heterotopia and the patient
with increased signal changes after subpial transection detected at
1.5 T, the detection rate drops to (8.7%). More recently, Zijlmans
et al.16 scanned 37 epileptic patients considered ineligible for
surgery based on available presurgical ﬁndings using a 1.5 T MR
(with an 8-channel phased array SENSE head coil) scanner and a
3.0 T MR scanner (with a similar phased-array head coil). The ﬁrst
experienced neuroradiologist identiﬁed 22 lesions on both 1.5 and
3.0 T studies while the second identiﬁed 28 lesions on the 1.5 TMR
study as opposed to 20 lesions on the 3.0 T MR study. Hence, in
total, fewer lesions were surprisingly identiﬁed on 3.0 T with
phased-array coil than on 1.5 T with phased-array coil. Sub-
analyses suggested that 3.0 T phased-array coil images might be
more liable to detect dysplasias while 1.5 T phased-array coil
images were better to detect tissue loss. Although this study
imaged a different population (i.e. patients ineligible for surgery
and not necessarily nonlesional) than ours and used phased-array
coils in both 1.5 and 3.0 T scans (making it impossible to determine
the beneﬁt of going from 1.5 to 3.0 T ﬁeld strengths independent
from the contribution of phased array coils), it provides argument
that the gain provided by imaging at higher ﬁeld is not necessarily
obvious nor remarkable.
Hence, in response to our question whether re-imaging our
nonlesional refractory patients was essential and what beneﬁts it
brought them, it would appear that the rate of detection of a new
epileptogenic lesion by 3.0 T structural imaging is low (5.6%)
though the impact of identifying such a lesion on clinical
management was signiﬁcant. One could advocate that despite
this low rate of detection, epilepsy surgery candidates with
negative 1.5 T MRI should still be re-imaged at 3.0 T considering it
could prevent a costly invasive EEG study with potential risks of
infection and haemorrhage as well as improve surgical outcome.
However, there is little to support re-imaging at 3.0 T patients with
well-controlled partial epilepsy. The frequency of lesions not
detected on standard-ﬁeld MRI is expected to be even lower in this
population as malformations of cortical development and hippo-
campal abnormalities are mostly encountered in refractory
patients.
The retrospective nature of our study introduced certain
limitations. As in other studies, some standard-ﬁeld MRIs were
performed in other centers where patients were previously
followed prior to referral to our institution. Although these centers
were afﬁliated academic centers using epilepsy protocols, small
differences in MR systems and acquisitions parameters could
result in variable image quality. Furthermore, there might be some
differences between neuroradiologists in their expertise withepilepsy MR studies. Finally, an unblinded reader reproduces
clinical practice but introduces a certain investigation bias in favor
of the 3.0 T. The delay between both 1.5 and 3.0 T MRI was
acceptable in our study to prevent introducing a bias that would be
related to progressive tissue changes. In any case, a longer delay
would have only created a bias in favor of 3.0 T MRI.
With the increasing availability of 3.0 TMR scanners for clinical
purposes along with phased-array coil development, more robust
data is clearly needed to provide recommendations. A prospective
study addressing issues mentioned above is currently underway in
our institution in which controls and patients with refractory
partial epilepsy with negative 1.5 T MRI will undergo three
additional MR studies: 1.5 T with phased-array coils, 3.0 and 3.0 T
with phased-array coils. Interpretation of images by two blinded
experienced neuroradiologists on two separate occasions, correla-
tion with other presurgical localization technique and intracere-
bral recordings or pathological examination when available,
assessment of impact on clinical management will be performed.
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